Terns Pharma: I Don't See The Positioning
Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.
What is William Blair’s Forecast for Amgen FY2025 Earnings?
Investment analysts at William Blair reduced their FY2025 earnings per share estimates for Amgen in a report released on Wednesday, February 5th. William Blair analyst M. Phipps now anticipates that ...
Bank of America Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock
Amgen (NASDAQ:AMGN – Get Free Report) had its target price raised by Bank of America from $256.00 to $275.00 in a report issued on Thursday,Benzinga reports. The firm currently has an “underperform” ...
Amgen Inc. stock underperforms Friday when compared to competitors
Shares of Amgen Inc. AMGN shed 1.42% to $293.54 Friday, on what proved to be an all-around dismal trading session for the ...
JD Supra12h
EU Biosimilar Regulatory and Launch Updates
CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars:  On January 30, 2025, the European Medicines Agency (EMA) Committee ...
Nancy A Grygiel Implements A Sell Strategy: Offloads $483K In Amgen Stock
What Happened: Grygiel's recent move involves selling 1,589 shares of Amgen. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total ...
Medscape21h
Romosozumab Improves Bone Strength in Women With T2D
Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...